JD Health International, Inc.HKEX: 6618

Inside information unaudited update on the 2026 third quarter

· Issued by JD Health International, Inc. via HKEXnews

Filed with HKEX · Stock code 6618 · · 3 pages · English

Summary by 6ix AI

The company reported significant growth in its pharmaceutical partnerships and expanded its delivery services across numerous cities. Additionally, JD Health highlighted advancements in AI technology for healthcare consultations and management during this period. The filing includes preliminary financial figures, indicating changes in revenue and profit compared to the previous year, though these figures are unaudited and subject to adjustment.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

JD Health International, Inc. on 6ix

Earlier from JD Health International

Later from JD Health International

All JD Health International news releases